Presentations -
-
6.EBUS-TBNAが診断に有用であった子宮頸癌肺転移の1例(第40回 日本呼吸器内視鏡学会中部支部会)
橋本 泉, 今井 直幸, 犬飼 朗博, 岩木 舞, 下方 智也, 森瀬 昌宏, 小川 知美, 山下 良, 田中 一大, 橋本 直純, 佐藤 光夫, 近藤 征史, 今泉 和良, 長谷川 好規
気管支学 2011 特定非営利活動法人 日本呼吸器内視鏡学会
-
Real-world evidence of crizotinib for ROS1-tested patients with non-small cell lung cancer in Japan International conference
Morise, M
ANNALS OF ONCOLOGY 2022.7
-
Hase, T; Yanagisawa, K; Fukatsu, A; Kimura, T; Kojima, E; Abe, T; Imaizumi, K; Horio, Y; Oguri, T; Yamamoto, M; Ogasawara, T; Sugino, Y; Morise, M; Nakatochi, M; Ando, M; Kondo, M; Saka, H; Saito, H; Hasegawa, Y; Takahashi, T
JOURNAL OF CLINICAL ONCOLOGY 2020.5.20
-
Impact of Combined Evaluation Using Tumor Volume and Metastatic Nodal Extent in Stage III NSCLC Treated with CRT International conference
Tamiya, Y; Morise, M; Matsuzawa, R; Tanaka, I; Okada, T; Iwano, S; Hase, T; Hashimoto, N; Sato, M; Itoh, Y; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET) International conference
Yanagitani, N; Takeuchi, S; Murayama, T; Yoshimura, K; Imai, Y; Takahara, S; Kawakami, T; Seto, T; Hattori, Y; Ohashi, K; Morise, M; Matsumoto, S; Yoh, K; Goto, K; Nishio, M; Yano, S
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status International conference
Koyama, J; Kimura, T; Oi, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kataoka, K; Matsuzawa, R; Fukihara, J; Sakamoto, K; Morise, M; Hashimoto, N; Kondoh, Y; Hasegawa, Y
ANNALS OF ONCOLOGY 2019.10
-
A PHASE II TRIAL OF ERLOTINIB FOR PREVIOUSLY TREATED JAPANESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATIONS: RESULTS OF THE CENTRAL JAPAN LUNG STUDY GROUP TRIAL (CJLSG0904). International conference
Hase, T; Morise, M; Taniguchi, H; Shindoh, J; Kojima, E; Tanikawa, Y; Suzuki, R; Ogasawara, T; Yamada, Y; Ando, M; Kondo, M; Saito, H; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2013.11
-
PROGNOSTIC FACTORS IN RECURRENT SMALL-CELL LUNG CARCINOMA International conference
Morise, M; Mizutani, T; Oguri, T; Imai, N; Hase, T; Shindo, Y; Inukai, Y; Ito, S; Hashimoto, N; Sato, M; Kondo, M; Hasegawa, Y
ANNALS OF ONCOLOGY 2012.10
-
Activity of tepotinib in brain metastases (BM): Preclinical models and clinical data from patients (pts) with MET exon 14 (METex14) skipping NSCLC International coauthorship International conference
Viteri S., Mazieres J., Veillon R., Felip E., Le X., Garassino M. C., Stanton T. S., Morise M., Lee J-S., Matsumoto S., De Marinis F., Wehler T., Clark A., Friese-Hamim M., Stroh C., Bruns R., Otto G., Paik P. K.
ANNALS OF ONCOLOGY 2020.9
-
Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET) International conference
Yanagitani N., Takeuchi S., Murayama T., Yoshimura K., Imai Y., Takahara S., Kawakami T., Seto T., Hattori Y., Ohashi K., Morise M., Matsumoto S., Yoh K., Goto K., Nishio M., Yano S.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
A nationwide genomic screening project for small cell lung cancer in Japan (LC-SCRUM-Japan) International conference
Daga Haruko, Umemura Shigeki, Ohe Yuichiro, Shiota Tetsuhiro, Fujita Masaki, Furuya Naoki, Tsuda Takeshi, Morise Masahiro, Matsumoto Shingo, Goto Koichi
ANNALS OF ONCOLOGY 2017.10
-
Weekly nab-PTX and weekly PTX for relapsed small cell lung cancer International conference
Oi H., Yamano Y., Yokoyama T., Matsuda T., Morise M., Kataoka K., Kimura T., Kondoh Y.
ANNALS OF ONCOLOGY 2019.11
-
UHRF1 as a Potential Therapeutic Target for KRAS Mutated Non-Small Cell Lung Cancer International conference
Goto D., Kizuki M., Uwatoko N., Kawai K., Koike M., Nakashima M., Miyazawa A., Tanaka I., Hase T., Morise M., Hasegawa Y., Minna J., Sato M.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
The Subunit eIF2 ss of Translation- Initiation Factor EIF2 Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer International conference
Sato Mitsuo, Tanaka Ichidai, Goto Daiki, Kato Toshio, Kakumu Tomohiko, Miyazawa Ayako, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Sekido Yoshitaka, Kondo Masashi, Hasegawa Yoshinori
CANCER SCIENCE 2018.12
-
Tepotinib in Patients with Advanced NSCLC with MET Exon 14 (METex14) Skipping: Overall Efficacy Results from VISION Cohort A International coauthorship International conference
Mazieres J., Paik P., Felip E., Veillon R., Sakai H., Cortot A., Viteri S., Garassino M., Van Meerbeeck J., Raskin J., Thomas M., Morise M., Cho B. C., Conte P., Bruns R., Demuth T., Schumacher K. M., Le X.
JOURNAL OF THORACIC ONCOLOGY 2021.1
-
Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data International coauthorship International conference
Sakai H., Felip E., Cortot A. B., Veillon R., Griesinger F., Patel J., Horn L., Mazieres J., De Castro Carpeno J., Morise M., Sakamoto T., Bruns R., Scheele J., Straub J., Paik P.
ANNALS OF ONCOLOGY 2018.11
-
Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A International coauthorship International conference
Mazieres J., Paik P. K., Felip E., Veillon R., Sakai H., Cortot A. B., Viteri S., Garassino M. C., Van Meerbeeck J. P., Raskin J., Thomas M., Morise M., Cho B. C., Conte P., Bruns R., Demuth T., Schumacher K. M., Le X.
ANNALS OF ONCOLOGY 2020.9
-
Tepotinib in NSCLC patients with METex14 mutations: interim results from the phase II VISION study International coauthorship International conference
Sakai Hiroshi, Veillon Remi, Cortot Alexis B., Felip Enriqueta, Mazieres Julien, Morise Masahiro, Sakamoto Tomohiro, Tokito Takaaki, Atagi Shinji, Kato Terufumi, Kumagai Toru, Tanaka Hiroshi, Bruns Rolf, Straub Josef, Scheele Juergen, Le Xiuning, Paik Paul K.
ANNALS OF ONCOLOGY 2019.10
-
Tepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study International conference
Park K., Felip E., Veillon R., Cortot A., Mazieres J., Sakai H., Reinmuth N., Viteri S., Chen Y-M., Han J-Y., Jang T-W., Morise M., Sakamoto T., Tokito T., Cho B. C., Bruns R., Scheele J., Straub J., Le X., Paik P. K.
ANNALS OF ONCOLOGY 2019.11
-
Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping International coauthorship International conference
Yang J. C-H., Le X., Cho B. C., Han J-Y., Morise M., Chen Y-M., Kang J-H., Kato T., Takeoka H., Chikamori K., Sakai H., Park K., Wu Y-L., Schumacher K., Bruns R., Straub J., Paik P.
ANNALS OF ONCOLOGY 2020.11